Recently Published Journals

Here are some of the fruits of our latest research–papers in recently published journals or in
press:

  1. Sabo M, Le L, Yaakov RA, Carter MJ, Serena TE. A post-marketing surveillance study of
    chronic wounds treated with a native collagen calcium alginate dressing. Ostomy Wound
    Manage. 2018;64:38-43.
  2. Snyder RJ, Kasper MA, Patel K, Carter MJ, Kushnir I, Kushnir A, Serena TE. Safety and
    efficacy of a novel autologous blood clot product in the management of Texas 1a or 2a
    neuropathic diabetic foot ulcers: A prospective, multicenter, open label pilot study.
    Wounds. 2018; in press.
  3. Edmonds ME, Bodansky HJ, Boulton AJ, Chadwick PJ, Dang CN, D’Costa R, Johnston A,
    Kennon B, Leese G, Rajbhandari SM, Serena TE, Young MJ, Stewart JE, Tucker
    AT, Carter MJ. Multicenter, randomized controlled, observer-blinded study of a nitric
    oxide generating treatment in foot ulcers of patients with diabetes – ProNOx1 study. Wound
    Repair Regen. 2018 Apr 4. [Epub ahead of print]
  4. Waycaster C, Carter MJ, Gilligan AM, Mearns ES, Fife CE, Milne CT. Comparative cost
    and clinical effectiveness of clostridial collagenase ointment for chronic dermal ulcers. J
    Comp Eff Res. 2018;7:149-165.
  5. Nussbaum SR, Carter MJ, Fife CE, DaVanzo J, Haught R, Nusgart M, Cartwright D. An
    economic evaluation of the impact, cost, and Medicare policy implications of chronic
    nonhealing wounds. Value in Health. 2018;21:27-32.
  6. Fife CE, Eckert KA, Carter MJ. Publicly reported wound healing rates: The fantasy and the
    reality. Adv Wound Care. 2017; Sep 28. [Epub ahead of print]
  7. Eckert KA, Lansingh VC, McLeod-Omawale J, Furtado JM, Martinez-Castro F, Carter MJ.
    Field testing project to pilot World Health Organization eye health indicators in Latin
    America. Ophthalmic Epidemiol. 2018;25:91-104.
  8. DiDomenico LA, Orgill DP, Galiano RD, Serena TE, Carter MJ, Kaufman JP, Young NJ,
    Zelen CM. A retrospective crossover study of the use of aseptically processed placental
    membrane in the treatment of chronic diabetic foot ulcers. Wounds. 2017 Jul 26. [Epub
    ahead of print]
  9. Carter MJ. Harnessing electronic healthcare data for wound care research: Wound registry
    analytic guidelines for less-biased analyses. Wound Repair Regen. 2017;25:564-573.
  10. Driver VR, Gould LJ, Dotson P, Gibbons GW, Li WW, Ennis WJ, Kirsner RS, Eaglstein
    WH, Bolton LL, Carter MJ. Identification and Content Validation of Wound Therapy
    Clinical Endpoints Relevant to Clinical practice and patient Values for FDA approval. Part
    1. Survey of the wound care community. Wound Repair Regen. 2017;25:454-465.
  11. Zelen CM, Orgill DP, Serena TE, Galiano RD, Carter MJ, DiDomenico LA, Kaufman JP,
    Keller J, Young NJ, Li WW. Human reticular acellular dermal matrix in the healing of
    chronic diabetic foot ulcerations that failed standard conservative treatment: A
    retrospective crossover study. Wounds. 2017;29:39-45.
  12. Gilligan AM, Waycaster CR, Bizier R, Chu BC, Carter MJ, Fife CE. Comparative
    effectiveness of clostridial collagenase ointment to medicinal honey for treatment of
    pressure ulcers. Adv Wound Care. 2017;6:125-34.
  13. Serena TE, Fife CE, Eckert KA, Yaakov RA, Carter MJ. A new approach to clinical
    research: Integrating clinical care, quality reporting, and research using a wound care
    network-based learning healthcare system. Wound Repair Regen. 2017;25:354-65.
  14. Carter MJ, Fife CE. Clinic visit frequency in wound care matters: data from the US wound
    registry. J Wound Care 2017;26(Sup1):S4-S10.

  15. DiDomenico LA, Orgill DP, Galiano RD, Serena TE, Carter MJ, Kaufman JP, Young NJ,
    Zelen CM. Aseptically processed placental membrane improves healing of diabetic foot
    ulcerations: prospective, randomized clinical trial. Plast Reconstr Surg Glob Open.
    2016;4:e1095.

  16. Carter MJ, Gilligan AM, Waycaster CR, Schaum K, Fife CE. Cost effectiveness of adding
    clostridial collagenase ointment to selective debridement in individuals with stage IV
    pressure ulcers. J Med Econ 2017;20:253-65.

  17. Driver VR, Eckert KA, Carter MJ, French MA. Cost-effectiveness of negative pressure
    wound therapy in patients with many comorbidities and severe wounds of various etiology.
    Wound Repair Regen 2016;24:1041-58.

  18. Fife CE, Eckert KA, Carter MJ. An update on the appropriate role for hyperbaric oxygen:
    indications and evidence. Plast Reconstr Surg 2016;138(3 Suppl):107S-16S.

  19. Li WW, Carter MJ, Mashiach E, Guthrie SD. Vascular assessment of wound healing: a
    clinical review. Int Wound J 2016 Jul 4. [Epub ahead of print]

  20. Eckert KA, Carter MJ, Lansingh VC, Silva JC, McLeod-Omawale J. Field testing project
    to pilot World Health Organization global eye health indicators in Latin America: lessons
    learned thus far. Community Eye Health. 2016;29:S01-4.

  21. Carter MJ, Gilligan AM, Waycaster CR, Fife CE. Treating pressure ulcers with clostridial
    collagenase ointment: Results from the US Wound Registry. Wound Repair Regen
    2016;24:904-912.

  22. Snyder RJ, Lantis J, Kirsner RS, Shah V, Molyneaux M, Carter MJ. Macrophages: A
    review of their role in wound healing and their therapeutic use. Wound Repair Regen
    2016;24:613-29.

  23. Zelen CM, Orgill DP, Serena T, Galiano R, Carter MJ, DiDomenico LA, Keller J,
    Kaufman J, Li WW. A prospective, randomised, controlled, multicentre clinical trial
    examining healing rates, safety and cost to closure of an acellular reticular allogenic human
    dermis versus standard of care in the treatment of chronic diabetic foot ulcers. Int Wound J.
    2016 Apr 12. [Epub ahead of print]

  24. Serena MD TE, Cullen BM, Bayliff SW, Gibson MC, Carter MJ, Chen L, et al. Defining a
    new diagnostic assessment parameter for wound care: elevated protease activity (EPA), an
    indicator of non-healing, for targeted protease-modulating treatment. Wound Repair Regen
    2016;24:589-95.

  25. Zelen CM, Serena TE, Gould L, Le L, Carter MJ, Keller J, Li WW. Treatment of chronic
    diabetic lower extremity ulcers with advanced therapies: a prospective, randomised,
    controlled, multi-centre comparative study examining clinical efficacy and cost. Int Wound
    J 2016;13:272-82.

  26. 26. Niezgoda JA, Serena TE, Carter MJ. Outcomes of radiation injuries using hyperbaric
    oxygen therapy: an observational cohort study. Adv Skin Wound Care 2016;29:12-19.

  27. Eckert KA, Carter MJ, Lansingh VC, Wilson DA, Furtado JM, Frick KD, Resnikoff S. A
    simple method for estimating the economic cost of productivity loss due to blindness and
    moderate and severe visual impairment. Ophthalmic Epidemiol 2015;22:349-55..

  28. Gould L, Abadir P, Brem H, Carter M, Conner-Kerr T, Davidson J, et al. Chronic wound
    repair and healing in older adults: current status and future research. Wound Repair Regen
    2015;23:1-13.

  29. Serena TE, Carter MJ, Le LT, Sabo MJ, DiMarco DT. A multi-center randomized
    controlled clinical trial evaluating the use of dehydrated human amnion/chorion membrane
    allografts and multi-layer compression therapy vs. multi-layer compression therapy alone
    in the treatment of venous leg ulcers. Wound Repair Regen 2014;22:688-93.

  30. Fife CE, Carter MJ, Walker D, Thomson B, Eckert KA. Diabetic foot ulcer off-loading:
    The gap between evidence and practice. Data from the US Wound Registry. Adv Skin
    Wound Care 2014;27:310-6.

  31. Zelen CM, Gould L, Serena TE, Carter MJ, Keller J, Li WW. A prospective, randomised,
    controlled, multi-centre comparative effectiveness study of healing using dehydrated
    human amnion/chorion membrane allograft, bioengineered skin substitute or standard of
    care for treatment of chronic lower extremity diabetic ulcers. Int Wound J 2014;12:724-32.

  32. Lansingh VC, Nano ME, Carter MJ, Zárate N, Resnikoff S, Eckert KA. Complexities and
    challenges of surgical data collection from cataract patients: comparison of cataract surgery
    rates between 2001 and 2008 in all provinces of Argentina. Arq Bras Oftalmol 2014;77:25-
    9.

  33. Carter MJ, Waycaster C, Schaum K, Gilligan AM. Cost-Effectiveness of three adjunct
    cellular/tissue-derived products used in the management of chronic venous leg ulcers.
    Value Health 2014;17:801-13.

  34. Carter MJ. Economic evaluations of guideline-based or strategic interventions for the
    prevention or treatment of chronic wounds. Appl Health Econ Health Policy 2014;12:373-
    89.

  35. Carter MJ. Health economics information in wound care: the elephant in the room. Adv
    Wound Care (New Rochelle) 2013;2:563-570.
  36. Apelqvist J, Aron S, Carter M, et al. International consensus. Making the case for cost effective
    wound management. London: Wounds International, 2013.
  37. Carter MJ, Fife CE, Bennett M. Comment on: Margolis et al. lack of Effectiveness of
    hyperbaric oxygen therapy for the treatment of diabetic foot ulcer and the prevention of
    amputation: a cohort study. Diabetes Care 2013;36:1961-1966. Diabetes Care [letter];
    2013;36:e131.
  38. Wilcox JR, Carter MJ, Covington S. Frequency of debridements and time to heal: A
    retrospective cohort study of 312,744 wounds. JAMA Dermatol 2013;149:1050-8.
  39. Lavett DK, Lansingh VC, Carter MJ, Eckert KA, Silva JC. Will the SAFE strategy be
    sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions.
    ScientificWorldJournal 2013;2013:648106.
  40. Nano ME, Lansingh VC, Pighin MS, Zarate N, Nano H, Carter MJ, Furtado JM, Nano CC,
    Vernengo LF, Luna JD, Eckert KA. Risk factors of age-related macular degeneration in
    Argentina. Arq Bras Oftalmol 2013; 76:80-4.
  41. Carter MJ, Lansingh VC, Schacht G, Rio M, Scalamogna M, France TD. Visual acuity and
    refraction by age for children of three different ethnic groups in Paraguay. Arq Bras
    Oftalmol 2013;76:94-7.
  42. Fife CE, Wall V, Carter MJ, Walker D, Thomson B, Turner T. Revenue in U.S. hospital
    based outpatient wound centers: implications for creating accountable care organizations. J
    Hospital Admin 2013;2:38-45.
  43. Yaacov-Peña F, Jure D, Ocampos J, Samudio M, Furtado JM, Carter M, Lansingh VC.
    Prevalence and causes of blindness in an urban area of Paraguay? Piribebuy Eye Study. Arq
    Bras Oftalmol 2012;75:341-3.
  44. Fife CE, Yankowsky K, Carter MJ. Do pressure ulcer prevention protocols improve patient
    Ulldemolins AR, Lansingh VC, Valencia LG, Carter MJ, Eckert KA. Social inequalities in
    blindness and visual impairment: a review of social determinants. Indian J Ophthalmol
    2012;60:368-75. (Invited review.)
  45. Warriner 3rd RA, Wilcox JR, Carter MJ, Stewart DG. More frequent visits to wound care
    clinics result in faster times to heal diabetic foot and venous leg ulcers. Adv Skin Wound
    Care 2012;25:494-501.
  46. Carter MJ, Limburg H, Lansingh VC, Silva JC, Resnikoff S. Do gender inequities exist in
    cataract surgical coverage? Meta-analysis in Latin America. Clin Experiment Ophthalmol
    2012;40:458-66.
  47. Serena T, Bates-Jensen B, Carter MJ, Cordrey R, Driver V, Fife CE, Haser PB, Krasner D,
    Nusgart M, Smith AP, Snyder RJ. Consensus principles for wound care research obtained
    using a Delphi process. Wound Repair Regen 2012;20:284-93.
  48. Fife CE, Carter MJ, Walker D, Thomson B. Wound care outcomes and associated cost
    among patients treated in U.S. outpatient wound centers: Data from the U.S. Wound
    Registry. Wounds 2012:24:10-17.
  49. Fife CE, Wall V, Carter MJ, Walker D, Thomson B. Is there a relationship between
    physician and facility billed level of service in outpatient wound centers? Ostomy Wound
    Manage 2012;58:20-2, 24, 26-8.
  50. Carter MJ, Fylling CP, Li WW, de Leon J, Driver VR, Serena TE, Wilson J. Analysis of
    run-in and treatment data in a wound outcomes registry: clinical impact of topical plateletrich
    plasma gel on healing trajectory. Int Wound J 2011;8:638-650.
  51. Furtado JM, Lansingh VC, Carter MJ, Milanese MF, Peña BN, Ghersi HA, Bote PL, Nano
    ME, Silva JC. Causes of blindness and visual impairment in Latin America. Survey
    Ophthalmol 2012;57:149-77.
  52. 53. Carter MJ, Fylling CP, Parnell LK. Use of platelet rich plasma gel on wound healing: A
    systematic review and meta-analysis. ePlasty 2011; 11:e38.
  53. Carter MJ, Fylling CP, Li WW, de Leon J, Driver VR, Serena TE, Wilson J. Analysis of runin
    and treatment data in a wound outcomes registry: clinical impact of topical platelet-rich
    plasma gel on healing trajectory. Int Wound J 2011; 8:638-50.
  54. de Leon JM, Driver VR, Fylling CP, Carter MJ, Anderson C, Wilson J, Dougherty RM,
    Fuston D, Trigilia D, Valenski V, Rappl LM. The clinical relevance of treating chronic
    wounds with an enhanced near-physiological concentration of platelet-rich plasma gel. Adv
    Skin Wound Care 2011;24:357-68.
  55. Lansingh VC, Carter MJ. State of the globe: the unglamorous side of infectious diseases:
    parasites. State of the globe: the unglamorous side of infectious diseases: parasites. J Glob
    Infect Dis 2011;3:113-4.
  56. Warriner RA III, Carter MJ. The current state of evidence-based protocols in wound care.
    Plast Reconstr Surg 2011;127 Suppl 1:144S-153S. (Invited review.)
  57. Carter MJ. Cost-effectiveness research in wound care: Definition, approaches, and
    limitations. Ostomy Wound Manage 2010;56:48-59. (Invited review)
  58. Quiroga L, Lansingh VC, Samudio M, Peña FY, Carter MJ. Characteristics of the corneal
    endothelium and pseudoexfoliation syndrome in patients with senile cataract. Clin Exp
    Ophthalmol 2010;38:449-55.
  59. Lansingh VC, Resnikoff S, Tingley-Kelley K, Nano ME, Martens M, Silva JC, Duerksen R,
    Carter MJ. Cataract surgery rates in Latin America: a four-year longitudinal study of 19
    countries. Ophthalmic Epidemiol 2010;17:75-81.
  60. Fife CE, Carter MJ, Walker D. Why is it so hard to do the right thing in wound care? Wound
    Repair Regen 2010;18:154-8.
  61. Fife CE, Maus EA, Carter MJ. Lipedema: A frequently misdiagnosed and misunderstood
    fatty deposition syndrome. Adv Skin Wound Care 2010;23:81-92; quiz 93-4.
  62. Carter MJ. Evidence-based medicine: An overview of key concepts. Ostomy Wound Manage
    2010 56:68-85. [Invited review]
  63. Fife CE, Carter MJ, Walker D, Thomson B. A retrospective data analysis of antimicrobial
    dressing usage in 3,084 patients. Ostomy Wound Manage 2010;56:28-42.
  64. Carter MJ, Tingley Kelley K, Warriner RA III. A systematic review and meta-analysis of
    silver-impregnated dressings. J Am Acad Dermatol 2010;63:668-679.
  65. Fife CE, Carter MJ. Lymphoedema in bariatric patients. J Lymphoedema 2009;4:29-37.
  66. Lansingh VC, Carter MJ. The use of global visual acuity data in a time trade-off approach to
    calculate the cost-utility of cataract surgery. Arch Ophthalmol 2009;127:1183-1193.
  67. Carter MJ, Fife CE, Thomson B, Walker D. Estimating the applicability of wound care
    randomized controlled trials to general wound-care populations by estimating the percentage
    of individuals excluded from a typical wound-care population in such trials. Adv Skin Wound
    Care 2009;22:316-324. (Winner of the 2009 Roberta Abruzzese Publishing Award.)
  68. Lansingh VC, Carter MJ. Does open access in ophthalmology affect how articles are
    subsequently cited in research? Ophthalmology 2009;116:1425-1431.
  69. Carter MJ, Warriner RA 3rd. Evidence-based medicine in wound care: time for a new
    paradigm. Adv Skin Wound Care 2009;22:12-16.
Share This